For: | Lee EC, Kim SH, Lee SD, Park H, Lee SA, Park SJ. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation. World J Gastroenterol 2016; 22(14): 3803-3812 [PMID: 27076765 DOI: 10.3748/wjg.v22.i14.3803] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i14/3803.htm |
Number | Citing Articles |
1 |
Stela Celaj, Josh Levitsky. Prevention and Management of HBV in Organ Transplantation. Current Hepatology Reports 2020; 19(3): 266 doi: 10.1007/s11901-020-00537-7
|
2 |
Peter Schemmer, Patrizia Burra, Rey‐Heng Hu, Christian M. Hüber, Carmelo Loinaz, Keigo Machida, Arndt Vogel, Didier Samuel. State of the art treatment of hepatitis B virus hepatocellular carcinoma and the role of hepatitis B surface antigen post‐liver transplantation and resection. Liver International 2022; 42(2): 288 doi: 10.1111/liv.15124
|
3 |
Ümit ÖZÇELİK, Eryiğit EREN, Tutkun TALİH, Ömer ÖZOZAN, Fatih ENSAROĞLU. Karaciğer Nakli Sonrası Hepatit B Nüksünün Önlenmesinde Kısa Süreli Düşük Doz Hepatit B İmmünglobulini ile Nükleotid Analoğu Kombinasyonunun Etkinliği. Bozok Tıp Dergisi 2020; doi: 10.16919/bozoktip.661595
|
4 |
Ranjit Chauhan, Shilpa Lingala, Chiranjeevi Gadiparthi, Nivedita Lahiri, Smruti R Mohanty, Jian Wu, Tomasz I Michalak, Sanjaya K Satapathy. Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management. World Journal of Hepatology 2018; 10(3): 352-370 doi: 10.4254/wjh.v10.i3.352
|
5 |
Kavita Radhakrishnan, Aileen Chi, David J. Quan, John P. Roberts, Norah A. Terrault. Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients. Transplantation 2017; 101(9): 2079 doi: 10.1097/TP.0000000000001786
|
6 |
Chad Nakagawa, Manjunatha Kadlera Nagaraj, Juan Carlos Hernandez, Dinesh Babu Uthay Kumar, Vivek Shukla, Risa Machida, Jörg Schüttrumpf, Linda Sher, Patrizia Farci, Lopa Mishra, Stanley M. Tahara, Jing-Hsiung James Ou, Keigo Machida. β-CATENIN stabilizes HIF2 through lncRNA and inhibits intravenous immunoglobulin immunotherapy. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1204907
|